Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth G Saag

Showing results (41-50 of 374) with videos related to

Pageof 38
Sort By:
Core Evidence|August 10, 2010
Febuxostat: the evidence for its use in the treatment of hyperuricemia and goutAngelo L Gaffo, Kenneth G Saag
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Evaluating and improving the quality of care in rheumatic diseaseJeffrey R Curtis, Kenneth G Saag
Current Opinion in Rheumatology|February 8, 2006
New insights into gout epidemiologyTed R Mikuls, Kenneth G Saag
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 26, 2024
Methotrexate: Use in the Post Dobbs v. Jackson EraEdward M Huddleston, Kenneth G Saag
Current Osteoporosis Reports|October 8, 2013
Prevention and treatment of bone changes associated with exposure to glucocorticoidsAmy H Warriner, Kenneth G Saag
Nature Reviews. Endocrinology|August 6, 2014
Fracture mortality: associations with epidemiology and osteoporosis treatmentSebastian E Sattui, Kenneth G Saag
Best Practice & Research. Clinical Rheumatology|December 1, 2009
PrefaceWillem F Lems, Kenneth G Saag
Current Rheumatology Reports|May 28, 2005
Recent advances in the epidemiology of goutKenneth G Saag, Ted R Mikuls
Arthritis Research & Therapy|November 6, 2008
Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicineAngelo L Gaffo, Kenneth G Saag
Best Practice & Research. Clinical Rheumatology|December 25, 2015
Evaluating and mitigating fracture risk in established rheumatoid arthritisMatthew B Mullen, Kenneth G Saag
Pageof 38

Showing results (41-50 of 374) with videos related to

Sort By:
Pageof 38
Core Evidence|August 10, 2010
Febuxostat: the evidence for its use in the treatment of hyperuricemia and goutAngelo L Gaffo, Kenneth G Saag
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Evaluating and improving the quality of care in rheumatic diseaseJeffrey R Curtis, Kenneth G Saag
Current Opinion in Rheumatology|February 8, 2006
New insights into gout epidemiologyTed R Mikuls, Kenneth G Saag
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|September 26, 2024
Methotrexate: Use in the Post Dobbs v. Jackson EraEdward M Huddleston, Kenneth G Saag
Current Osteoporosis Reports|October 8, 2013
Prevention and treatment of bone changes associated with exposure to glucocorticoidsAmy H Warriner, Kenneth G Saag
Nature Reviews. Endocrinology|August 6, 2014
Fracture mortality: associations with epidemiology and osteoporosis treatmentSebastian E Sattui, Kenneth G Saag
Best Practice & Research. Clinical Rheumatology|December 1, 2009
PrefaceWillem F Lems, Kenneth G Saag
Current Rheumatology Reports|May 28, 2005
Recent advances in the epidemiology of goutKenneth G Saag, Ted R Mikuls
Arthritis Research & Therapy|November 6, 2008
Serum urate, menopause, and postmenopausal hormone use: from eminence to evidence-based medicineAngelo L Gaffo, Kenneth G Saag
Best Practice & Research. Clinical Rheumatology|December 25, 2015
Evaluating and mitigating fracture risk in established rheumatoid arthritisMatthew B Mullen, Kenneth G Saag
Pageof 38